On the public citation graph
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
0 signed · 871 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/j.immuni.2007.01.009openalex-snapshot
Autoreactivity in Human IgG+ Memory B Cells
inferredcites →https://doi.org/10.1016/j.jim.2007.09.017openalex-snapshot
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
inferredcites →https://doi.org/10.1016/j.jim.2008.11.012openalex-snapshot
A method for identification of HIV gp140 binding memory B cells in human blood
inferredcites →https://doi.org/10.1038/31405openalex-snapshot
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
inferredcites →https://doi.org/10.1038/5568openalex-snapshot
Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys
inferredcites →https://doi.org/10.1038/nature01470openalex-snapshot
Antibody neutralization and escape by HIV-1
inferredcites →https://doi.org/10.1038/nature05580openalex-snapshot
Structural definition of a conserved neutralization epitope on HIV-1 gp120
inferredcites →https://doi.org/10.1038/nm1244openalex-snapshot
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
inferredcites →https://doi.org/10.1038/nm1624openalex-snapshot
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
inferredcites →https://doi.org/10.1038/nri1307openalex-snapshot
Identifying epitopes of HIV-1 that induce protective antibodies
inferredcites →https://doi.org/10.1038/nrmicro1819openalex-snapshot
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
inferredcites →https://doi.org/10.1073/pnas.0308527100openalex-snapshot
Structural basis of tyrosine sulfation and V H -gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120
inferredcites →https://doi.org/10.1073/pnas.0803644105openalex-snapshot
Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors
inferredcites →https://doi.org/10.1073/pnas.88.22.10134openalex-snapshot
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.
inferredcites →https://doi.org/10.1089/aid.1994.10.359openalex-snapshot
Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization
inferredcites →https://doi.org/10.1126/science.1086907openalex-snapshot
Predominant Autoantibody Production by Early Human B Cell Precursors
inferredcites →https://doi.org/10.1128/jvi.64.12.5701-5707.1990openalex-snapshot
Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding
inferredcites →https://doi.org/10.1128/jvi.65.11.6188-6193.1991openalex-snapshot
Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody
inferredcites →https://doi.org/10.1128/jvi.65.9.4832-4838.1991openalex-snapshot
Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies
inferredcites →https://doi.org/10.1128/jvi.66.12.7538-7542.1992openalex-snapshot
Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody
inferredcites →https://doi.org/10.1128/jvi.67.11.6642-6647.1993openalex-snapshot
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
inferredcites →https://doi.org/10.1128/jvi.67.7.3978-3988.1993openalex-snapshot
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
inferredcites →https://doi.org/10.1128/jvi.70.2.1100-1108.1996openalex-snapshot
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
inferredcites →https://doi.org/10.1128/jvi.73.5.4009-4018.1999openalex-snapshot
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies
inferredcites →https://doi.org/10.1128/jvi.74.12.5716-5725.2000openalex-snapshot
Characterization of Stable, Soluble Trimers Containing Complete Ectodomains of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins
inferredcites →https://doi.org/10.1128/jvi.75.22.10892-10905.2001openalex-snapshot
Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41
inferredcites →https://doi.org/10.1128/jvi.77.1.642-658.2003openalex-snapshot
Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120
inferredcites →https://doi.org/10.1128/jvi.79.16.10108-10125.2005openalex-snapshot
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3381953openalex-extracted
Maternal Broadly Neutralizing Antibodies Select for Neutralization-Resistant Infant Transmitted/Founder HIV Variants
inferred← citeshttps://doi.org/10.1002/adma.201305759openalex-snapshot
High‐Density Peptide Arrays with Combinatorial Laser Fusing
inferred← citeshttps://doi.org/10.1002/art.38754openalex-snapshot
Barcode‐Enabled Sequencing of Plasmablast Antibody Repertoires in Rheumatoid Arthritis
inferred← citeshttps://doi.org/10.1002/bit.25663openalex-snapshot
Automated pipeline for rapid production and screening of HIV‐specific monoclonal antibodies using pichia pastoris
inferred← citeshttps://doi.org/10.1002/cmdc.201000292openalex-snapshot
Inhibition of HIV‐1 Entry: Multiple Keys to Close the Door
inferred← citeshttps://doi.org/10.1002/eji.201242974openalex-snapshot
Identification of a new epitope for HIV‐neutralizing antibodies in the gp41 membrane proximal external region by an Env‐tailored phage display library
inferred← citeshttps://doi.org/10.1002/eji.201343917openalex-snapshot
Single‐cell based high‐throughput sequencing of full‐length immunoglobulin heavy and light chain genes
inferred← citeshttps://doi.org/10.1002/eji.201344305openalex-snapshot
Independent evolution of Fc‐ and Fab‐mediated HIV‐1‐specific antiviral antibody activity following acute infection
inferred← citeshttps://doi.org/10.1002/eji.201344433openalex-snapshot
Dendritic cell‐based therapeutic vaccine elicits polyfunctional HIV‐specific T‐cell immunity associated with control of viral load
inferred← citeshttps://doi.org/10.1002/eji.201545526openalex-snapshot
Direct high‐throughput amplification and sequencing of immunoglobulin genes from single human B cells
inferred← citeshttps://doi.org/10.1002/ejoc.201100296openalex-snapshot
Carbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation
inferred← citeshttps://doi.org/10.1002/jia2.26039openalex-snapshot
Forty years of investment in HIV research: progress towards ending the HIV pandemic and preparation for future pandemics
inferred← citeshttps://doi.org/10.1002/jmr.1116openalex-snapshot
Limitations to the structure‐based design of HIV‐1 vaccine immunogens
inferred← citeshttps://doi.org/10.1002/jmr.1138openalex-snapshot
Survey of the 2009 commercial optical biosensor literature
inferred← citeshttps://doi.org/10.1002/jmv.29488openalex-snapshot
The characteristics of BCR‐CDR3 repertoire in COVID‐19 patients and SARS‐CoV‐2 vaccinated volunteers
inferred← citeshttps://doi.org/10.1002/mma.4102openalex-snapshot
Global dynamics of an age‐structured virus model with saturation effects
inferred← citeshttps://doi.org/10.1002/pro.2750openalex-snapshot
Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus‐1 gp41 and equine infectious anemia virus gp45
inferred← citeshttps://doi.org/10.1002/rmv.1853openalex-snapshot
Protein/peptide‐based entry/fusion inhibitors as anti‐HIV therapies: challenges and future direction
inferred← citeshttps://doi.org/10.1007/82_2018_103openalex-snapshot
Targeting Glycans on Human Pathogens for Vaccine Design
inferred← citeshttps://doi.org/10.1007/82_2020_221openalex-snapshot
Broadly Neutralizing Antibodies to Highly Antigenically Variable Viruses as Templates for Vaccine Design
inferred← citeshttps://doi.org/10.1007/978-1-0716-0581-3_20openalex-snapshot
Isolation of Monoclonal Antibodies from Zika Virus-Infected Patient Samples
inferred← citeshttps://doi.org/10.1007/978-1-4939-2963-4_17openalex-snapshot
Laboratory and Data Analysis Methods for Characterization of Human B Cell Repertoires by High-Throughput DNA Sequencing
inferred← citeshttps://doi.org/10.1007/978-3-030-32459-9_12openalex-snapshot
Limitations to the Structure-Based Design of HIV-1 Vaccine Immunogens
inferred← citeshttps://doi.org/10.1007/978-3-030-32459-9_14openalex-snapshot
Requirements for Empirical Immunogenicity Trials, Rather than Structure-Based Design, for Developing an Effective HIV Vaccine
inferred← citeshttps://doi.org/10.1007/978-3-030-32459-9_17openalex-snapshot
An Outdated Notion of Antibody Specificity Is One of the Major Detrimental Assumptions of the Structure-Based Reverse Vaccinology Paradigm, Which Prevented It from Helping to Develop an Effective HIV-1 Vaccine
inferred← citeshttps://doi.org/10.1007/978-3-030-32459-9_21openalex-snapshot
Structure-Based Reverse Vaccinology Failed in the Case of HIV Because It Disregarded Accepted Immunological Theory
inferred← citeshttps://doi.org/10.1007/978-3-030-32459-9_9openalex-snapshot
Basic Research in HIV Vaccinology Is Hampered by Reductionist Thinking
inferred← citeshttps://doi.org/10.1007/978-3-0346-0219-8_4openalex-snapshot
Characteristics of B Cells and B Cell Responses in Aged Individuals
inferred← citeshttps://doi.org/10.1007/978-3-319-20726-1_10openalex-snapshot
Microscale Technologies for High-Throughput Analysis of Immune Cells
inferred← citeshttps://doi.org/10.1007/978-3-319-29716-3_16openalex-snapshot
Evolutionary Principles and Host Defense
inferred← citeshttps://doi.org/10.1007/978-981-13-0484-2_3openalex-snapshot
HIV Broadly Neutralizing Antibodies: VRC01 and Beyond
inferred← citeshttps://doi.org/10.1007/978-981-13-0502-3_8openalex-snapshot
Therapeutic Antibody Discovery in Infectious Diseases Using Single-Cell Analysis
inferred← citeshttps://doi.org/10.1007/s00018-011-0872-6openalex-snapshot
Polyreactive antibodies in adaptive immune responses to viruses
inferred← citeshttps://doi.org/10.1007/s00018-012-0971-zopenalex-snapshot
IgM memory B cells: a mouse/human paradox
inferred← citeshttps://doi.org/10.1007/s00253-019-09998-3openalex-snapshot
Germinality does not necessarily define mAb expression and thermal stability
inferred← citeshttps://doi.org/10.1007/s00705-011-1145-2openalex-snapshot
Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine
inferred← citeshttps://doi.org/10.1007/s00705-016-2942-4openalex-snapshot
VRC01 antibody protects against vaginal and rectal transmission of human immunodeficiency virus 1 in hu-BLT mice
inferred← citeshttps://doi.org/10.1007/s00705-019-04173-5openalex-snapshot
Induction of neutralizing antibodies against tier 2 human immunodeficiency virus 1 in rhesus macaques infected with tier 1B simian/human immunodeficiency virus
inferred← citeshttps://doi.org/10.1007/s00705-020-04777-2openalex-snapshot
Review of preventative HIV vaccine clinical trials in South Africa
inferred← citeshttps://doi.org/10.1007/s10473-021-0322-yopenalex-snapshot
Dynamics Analysis of a Delayed HIV Infection Model with CTL Immune Response and Antibody Immune Response
inferred← citeshttps://doi.org/10.1007/s10875-014-0010-yopenalex-snapshot
Highly Efficient Neutralization by Plasma Antibodies from Human Immunodeficiency Virus Type-1 Infected Individuals on Antiretroviral Drug Therapy
inferred← citeshttps://doi.org/10.1007/s11427-013-4591-0openalex-snapshot
10E8-like neutralizing antibodies against HIV-1 induced using a precisely designed conformational peptide as a vaccine prime
inferred← citeshttps://doi.org/10.1007/s11427-013-4593-yopenalex-snapshot
Persistence of VRC01-resistant HIV-1 during antiretroviral therapy
inferred← citeshttps://doi.org/10.1007/s11684-019-0721-9openalex-snapshot
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
inferred← citeshttps://doi.org/10.1007/s11904-010-0064-2openalex-snapshot
Alterations of the B-Cell Response by HIV-1 Replication
inferred← citeshttps://doi.org/10.1007/s11904-011-0105-5openalex-snapshot
Neutralizing Antibodies and Control of HIV: Moves and Countermoves
inferred← citeshttps://doi.org/10.1007/s12026-012-8268-8openalex-snapshot
Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology
inferred← citeshttps://doi.org/10.1007/s12250-021-00361-3openalex-snapshot
Exploration of a Sequential Gp140-Gp145 Immunization Regimen with Heterologous Envs to Induce a Protective Cross-Reactive HIV Neutralizing Antibody Response In Non-human Primates
inferred← citeshttps://doi.org/10.1007/s13238-010-0052-8openalex-snapshot
Monoclonal antibodies — a proven and rapidly expanding therapeutic modality for human diseases
inferred← citeshttps://doi.org/10.1007/s13238-018-0534-7openalex-snapshot
The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects
inferred← citeshttps://doi.org/10.1007/s15006-015-3167-2openalex-snapshot
Mögliche Strategien zur HIV-Prävention und -Therapie
inferred← citeshttps://doi.org/10.1016/b978-0-12-387715-4.00010-1openalex-snapshot
Immune Responses Associated to Viral Control
inferred← citeshttps://doi.org/10.1016/b978-0-12-397933-9.00024-2openalex-snapshot
The Cellular and Molecular Biology of HIV-1 Broadly Neutralizing Antibodies
inferred← citeshttps://doi.org/10.1016/b978-0-12-404734-1.00015-2openalex-snapshot
The Different Modes of Resistance to AIDS
inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.02532-0openalex-snapshot
Antigenic Variation☆
inferred← citeshttps://doi.org/10.1016/b978-0-12-809633-8.20249-5openalex-snapshot
Immunoglobulin Clonotype and Ontogeny Inference
inferred← citeshttps://doi.org/10.1016/b978-0-12-824010-6.00061-7openalex-snapshot
Single B-cell sequencing in monoclonal antibody discovery
inferred← citeshttps://doi.org/10.1016/b978-0-323-35761-6.00029-8openalex-snapshot
Human Immunodeficiency Virus Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-47927-1.00026-8openalex-snapshot
Structure and Derivation of Autoantibodies
inferred← citeshttps://doi.org/10.1016/b978-0-323-95502-7.00058-0openalex-snapshot
Immunoglobulin Clonotype and Ontogeny Inference
inferred← citeshttps://doi.org/10.1016/b978-0-443-28934-7.00007-8openalex-snapshot
Further therapeutic applications of mRNA and saRNA
inferred← citeshttps://doi.org/10.1016/b978-0-8089-2442-5.00003-1openalex-snapshot
10.1016/b978-0-8089-2442-5.00003-1
inferred← citeshttps://doi.org/10.1016/b978-0-8089-2442-5.00008-0openalex-snapshot
10.1016/b978-0-8089-2442-5.00008-0
inferred← citeshttps://doi.org/10.1016/b978-1-4160-3611-1.50054-4openalex-snapshot
Human immunodeficiency virus vaccines
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0090-5.00054-9openalex-snapshot
Human immunodeficiency virus vaccines
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0695-2.00003-1openalex-snapshot
Molecular biology of HIV
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0695-2.00008-0openalex-snapshot
The design of a global HIV vaccine
inferred← citeshttps://doi.org/10.1016/j.addr.2016.01.013openalex-snapshot
Engineering broadly neutralizing antibodies for HIV prevention and therapy
inferred← citeshttps://doi.org/10.1016/j.amepre.2015.09.004openalex-snapshot
Prospects for a Globally Effective HIV-1 Vaccine
inferred← citeshttps://doi.org/10.1016/j.antiviral.2009.08.007openalex-snapshot
Effector mechanisms in HIV-1 infected elite controllers: Highly active immune responses?
inferred← citeshttps://doi.org/10.1016/j.antiviral.2014.02.013openalex-snapshot
The past, present and future of neutralizing antibodies for hepatitis C virus
inferred← citeshttps://doi.org/10.1016/j.antiviral.2015.02.006openalex-snapshot
Reconstitution and characterization of antibody repertoires of HIV-1-infected “elite neutralizers”
inferred← citeshttps://doi.org/10.1016/j.antiviral.2016.06.013openalex-snapshot
Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120
inferred← citeshttps://doi.org/10.1016/j.antiviral.2021.105105openalex-snapshot
An antibody engineering platform using amino acid networks: A case study in development of antiviral therapeutics
inferred← citeshttps://doi.org/10.1016/j.antiviral.2022.105297openalex-snapshot
Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants
inferred← citeshttps://doi.org/10.1016/j.antiviral.2024.106015openalex-snapshot
Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions
inferred← citeshttps://doi.org/10.1016/j.antiviral.2025.106236openalex-snapshot
Decreased CD4+ T cell counts drive aberrant B cell repertoire alterations in people living with HIV
inferred← citeshttps://doi.org/10.1016/j.bbapap.2014.05.010openalex-snapshot
Immunogen design for HIV-1 and influenza
inferred← citeshttps://doi.org/10.1016/j.bbrc.2012.08.013openalex-snapshot
Fusion proteins of HIV-1 envelope glycoprotein gp120 with CD4-induced antibodies showed enhanced binding to CD4 and CD4 binding site antibodies
inferred← citeshttps://doi.org/10.1016/j.bcp.2021.114724openalex-snapshot
Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)
inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.02.079openalex-snapshot
Blocking HIV-1 entry by a gp120 surface binding inhibitor
inferred← citeshttps://doi.org/10.1016/j.cell.2013.03.018openalex-snapshot
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
inferred← citeshttps://doi.org/10.1016/j.cell.2014.01.052openalex-snapshot
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
inferred← citeshttps://doi.org/10.1016/j.cell.2014.06.022openalex-snapshot
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
inferred← citeshttps://doi.org/10.1016/j.cell.2014.08.023openalex-snapshot
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
inferred← citeshttps://doi.org/10.1016/j.cell.2015.03.004openalex-snapshot
Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection
inferred← citeshttps://doi.org/10.1016/j.cell.2015.06.003openalex-snapshot
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
inferred← citeshttps://doi.org/10.1016/j.cell.2016.02.022openalex-snapshot
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
inferred← citeshttps://doi.org/10.1016/j.cell.2016.07.030openalex-snapshot
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
inferred← citeshttps://doi.org/10.1016/j.cell.2017.06.048openalex-snapshot
Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo
inferred← citeshttps://doi.org/10.1016/j.cell.2018.03.061openalex-snapshot
Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses
inferred← citeshttps://doi.org/10.1016/j.cell.2019.11.003openalex-snapshot
High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity
inferred← citeshttps://doi.org/10.1016/j.cell.2020.05.025openalex-snapshot
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
inferred← citeshttps://doi.org/10.1016/j.cell.2021.04.032openalex-snapshot
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
inferred← citeshttps://doi.org/10.1016/j.celrep.2014.04.001openalex-snapshot
Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike
inferred← citeshttps://doi.org/10.1016/j.celrep.2015.12.017openalex-snapshot
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site
inferred← citeshttps://doi.org/10.1016/j.celrep.2019.03.032openalex-snapshot
HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells
inferred← citeshttps://doi.org/10.1016/j.celrep.2019.09.058openalex-snapshot
Injection of Antibodies against Immunodominant Epitopes Tunes Germinal Centers to Generate Broadly Neutralizing Antibodies
inferred← citeshttps://doi.org/10.1016/j.celrep.2020.107981openalex-snapshot
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature
inferred← citeshttps://doi.org/10.1016/j.celrep.2021.109084openalex-snapshot
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies
inferred← citeshttps://doi.org/10.1016/j.celrep.2021.109823openalex-snapshot
High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines
inferred← citeshttps://doi.org/10.1016/j.celrep.2022.110757openalex-snapshot
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants
inferred← citeshttps://doi.org/10.1016/j.celrep.2025.115334openalex-snapshot
Competition propels, rather than limits, the success of low-affinity B cells in the germinal center response
inferred← citeshttps://doi.org/10.1016/j.celrep.2025.116000openalex-snapshot
Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses
inferred← citeshttps://doi.org/10.1016/j.celrep.2025.116545openalex-snapshot
Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIV
inferred← citeshttps://doi.org/10.1016/j.cels.2019.09.007openalex-snapshot
Harnessing Avidity: Quantifying the Entropic and Energetic Effects of Linker Length and Rigidity for Multivalent Binding of Antibodies to HIV-1
inferred← citeshttps://doi.org/10.1016/j.chom.2009.09.008openalex-snapshot
Mining the B Cell Repertoire for Broadly Neutralizing Monoclonal Antibodies to HIV-1
inferred← citeshttps://doi.org/10.1016/j.chom.2012.09.008openalex-snapshot
A Blueprint for HIV Vaccine Discovery
inferred← citeshttps://doi.org/10.1016/j.chom.2012.10.002openalex-snapshot
Innate Immune Sensing of HIV-1 by Dendritic Cells
inferred← citeshttps://doi.org/10.1016/j.chom.2018.09.001openalex-snapshot
HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth
inferred← citeshttps://doi.org/10.1016/j.chom.2020.01.027openalex-snapshot
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage
inferred← citeshttps://doi.org/10.1016/j.chom.2020.05.010openalex-snapshot
A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations
inferred← citeshttps://doi.org/10.1016/j.chom.2023.05.025openalex-snapshot
Mapping the neutralizing specificity of human anti-HIV serum by deep mutational scanning
inferred← citeshttps://doi.org/10.1016/j.chom.2023.06.006openalex-snapshot
Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller
inferred← citeshttps://doi.org/10.1016/j.cimid.2018.09.009openalex-snapshot
Use of camel single-domain antibodies for the diagnosis and treatment of zoonotic diseases
inferred← citeshttps://doi.org/10.1016/j.coi.2011.04.006openalex-snapshot
High throughput cellular screens to interrogate the human T and B cell repertoires
inferred← citeshttps://doi.org/10.1016/j.coi.2013.09.011openalex-snapshot
Spontaneous activation of RNA-sensing pathways in autoimmune disease
inferred← citeshttps://doi.org/10.1016/j.coi.2014.02.010openalex-snapshot
Clonal and cellular dynamics in germinal centers
inferred← citeshttps://doi.org/10.1016/j.coi.2017.03.002openalex-snapshot
Role of germinal centers for the induction of broadly-reactive memory B cells
inferred← citeshttps://doi.org/10.1016/j.coi.2020.03.013openalex-snapshot
Innovations in structure-based antigen design and immune monitoring for next generation vaccines
inferred← citeshttps://doi.org/10.1016/j.coisb.2020.10.002openalex-snapshot
Antigen discovery tools for adaptive immune receptor repertoire research
inferred← citeshttps://doi.org/10.1016/j.coviro.2011.07.005openalex-snapshot
No acquisition: A new ambition for HIV vaccine development?
inferred← citeshttps://doi.org/10.1016/j.coviro.2015.04.002openalex-snapshot
Strategies to guide the antibody affinity maturation process
inferred← citeshttps://doi.org/10.1016/j.coviro.2022.101211openalex-snapshot
Broadly neutralizing antibodies against HIV-1 and concepts for application
inferred← citeshttps://doi.org/10.1016/j.crimmu.2021.03.002openalex-snapshot
Hybridoma technology: is it still useful?
inferred← citeshttps://doi.org/10.1016/j.crmeth.2023.100509openalex-snapshot
Increasing sensitivity of antibody-antigen interactions using photo-cross-linking
inferred← citeshttps://doi.org/10.1016/j.drudis.2011.08.013openalex-snapshot
HIV vaccine: hopes and hurdles
inferred← citeshttps://doi.org/10.1016/j.ebiom.2017.05.029openalex-snapshot
HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection
inferred← citeshttps://doi.org/10.1016/j.eimc.2011.01.006openalex-snapshot
Inmunopatogenia de la infección por el virus de la inmunodeficiencia humana
inferred← citeshttps://doi.org/10.1016/j.febslet.2013.11.005openalex-snapshot
Profiling the IgOme: Meeting the challenge
inferred← citeshttps://doi.org/10.1016/j.humimm.2021.10.007openalex-snapshot
Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients
inferred← citeshttps://doi.org/10.1016/j.idc.2014.08.004openalex-snapshot
Human Immunodeficiency Virus Vaccines
inferred← citeshttps://doi.org/10.1016/j.imlet.2012.08.002openalex-snapshot
Models and methods for analysis of lymphocyte repertoire generation, development, selection and evolution
inferred← citeshttps://doi.org/10.1016/j.imlet.2017.06.001openalex-snapshot
Human IgG repertoire of malaria antigen-immunized human immune system (HIS) mice
inferred← citeshttps://doi.org/10.1016/j.imlet.2021.11.001openalex-snapshot
Mechanisms underpinning poor antibody responses to vaccines in ageing
inferred← citeshttps://doi.org/10.1016/j.immuni.2010.09.011openalex-snapshot
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
inferred← citeshttps://doi.org/10.1016/j.immuni.2010.10.008openalex-snapshot
From Vaccines to Memory and Back
inferred← citeshttps://doi.org/10.1016/j.immuni.2012.08.012openalex-snapshot
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
inferred← citeshttps://doi.org/10.1016/j.immuni.2014.04.009openalex-snapshot
Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
inferred← citeshttps://doi.org/10.1016/j.immuni.2016.08.016openalex-snapshot
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
inferred← citeshttps://doi.org/10.1016/j.immuni.2019.04.014openalex-snapshot
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
inferred← citeshttps://doi.org/10.1016/j.immuni.2019.09.001openalex-snapshot
Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus
inferred← citeshttps://doi.org/10.1016/j.immuni.2020.10.005openalex-snapshot
Polyreactive Broadly Neutralizing B Cells are Selected to Provide Defense Against Pandemic Threat Influenza Viruses
inferred← citeshttps://doi.org/10.1016/j.immuni.2021.03.023openalex-snapshot
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
inferred← citeshttps://doi.org/10.1016/j.immuni.2021.07.008openalex-snapshot
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
inferred← citeshttps://doi.org/10.1016/j.immuni.2021.12.003openalex-snapshot
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization
inferred← citeshttps://doi.org/10.1016/j.immuni.2022.07.020openalex-snapshot
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses
inferred← citeshttps://doi.org/10.1016/j.it.2014.02.010openalex-snapshot
Emerging concepts on T follicular helper cell dynamics in HIV infection
inferred← citeshttps://doi.org/10.1016/j.it.2014.04.005openalex-snapshot
Studying the antibody repertoire after vaccination: practical applications
inferred← citeshttps://doi.org/10.1016/j.it.2014.08.007openalex-snapshot
Antibody B cell responses in HIV-1 infection
inferred← citeshttps://doi.org/10.1016/j.it.2014.09.004openalex-snapshot
Characterizing immune repertoires by high throughput sequencing: strategies and applications
inferred← citeshttps://doi.org/10.1016/j.it.2016.01.007openalex-snapshot
HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies
inferred← citeshttps://doi.org/10.1016/j.jaci.2012.04.006openalex-snapshot
Allergen specificity of IgG4-expressing B cells in patients with grass pollen allergy undergoing immunotherapy
inferred← citeshttps://doi.org/10.1016/j.jbc.2021.100745openalex-snapshot
50 Years of structural immunology
inferred← citeshttps://doi.org/10.1016/j.jdermsci.2023.04.006openalex-snapshot
Targeting the elevated IFN-γ in vitiligo patients by human anti- IFN-γ monoclonal antibody hampers direct cytotoxicity in melanocyte
inferred← citeshttps://doi.org/10.1016/j.jim.2009.08.009openalex-snapshot
Cloning and expression of murine Ig genes from single B cells
inferred← citeshttps://doi.org/10.1016/j.jim.2011.05.010openalex-snapshot
Flow cytometry based identification of simian immunodeficiency virus Env-specific B lymphocytes
inferred← citeshttps://doi.org/10.1016/j.jim.2012.09.003openalex-snapshot
Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells
inferred← citeshttps://doi.org/10.1016/j.jim.2013.09.003openalex-snapshot
Isolation of HIV-1-reactive antibodies using cell surface-expressed gp160ΔcBaL
inferred← citeshttps://doi.org/10.1016/j.jim.2014.11.003openalex-snapshot
Vaccine-induced plasmablast responses in rhesus macaques: Phenotypic characterization and a source for generating antigen-specific monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.jim.2015.01.011openalex-snapshot
Amplification of highly mutated human Ig lambda light chains from an HIV-1 infected patient
inferred← citeshttps://doi.org/10.1016/j.jim.2015.04.010openalex-snapshot
Efficient generation of human IgA monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.jim.2016.02.020openalex-snapshot
An antigen-specific, four-color, B-cell FluoroSpot assay utilizing tagged antigens for detection
inferred← citeshttps://doi.org/10.1016/j.jim.2016.09.001openalex-snapshot
Refined protocol for generating monoclonal antibodies from single human and murine B cells
inferred← citeshttps://doi.org/10.1016/j.jim.2016.09.007openalex-snapshot
Rapid high-throughput cloning and stable expression of antibodies in HEK293 cells
inferred← citeshttps://doi.org/10.1016/j.jim.2018.07.007openalex-snapshot
Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus
inferred← citeshttps://doi.org/10.1016/j.jim.2019.112734openalex-snapshot
Isolation of single HIV-1 Envelope specific B cells and antibody cloning from immunized rhesus macaques
inferred← citeshttps://doi.org/10.1016/j.jim.2024.113747openalex-snapshot
Optimizing the method for expressing human monoclonal antibodies from a single peripheral blood cell from vaccinated donors
inferred← citeshttps://doi.org/10.1016/j.jmb.2012.11.010openalex-snapshot
Rapid Conformational Epitope Mapping of Anti-gp120 Antibodies with a Designed Mutant Panel Displayed on Yeast
inferred← citeshttps://doi.org/10.1016/j.jmgm.2015.08.003openalex-snapshot
Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2015.11.006openalex-snapshot
Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination
inferred← citeshttps://doi.org/10.1016/j.jtbi.2010.11.009openalex-snapshot
Consequences of host heterogeneity, epitope immunodominance, and immune breadth for strain competition
inferred← citeshttps://doi.org/10.1016/j.jviromet.2012.07.011openalex-snapshot
Optimization and proficiency testing of a pseudovirus-based assay for detection of HIV-1 neutralizing antibody in China
inferred← citeshttps://doi.org/10.1016/j.jviromet.2013.01.016openalex-snapshot
Complete and repeatable inactivation of HIV-1 viral particles in suspension using a photo-labeled non-nucleoside reverse transcriptase inhibitor
inferred← citeshttps://doi.org/10.1016/j.molimm.2015.04.011openalex-snapshot
A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site
inferred← citeshttps://doi.org/10.1016/j.molimm.2015.12.002openalex-snapshot
Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations
inferred← citeshttps://doi.org/10.1016/j.molimm.2018.09.020openalex-snapshot
Using single cell analysis for translational studies in immune mediated diseases: Opportunities and challenges
inferred← citeshttps://doi.org/10.1016/j.molmed.2010.10.008openalex-snapshot
B cell responses to HIV-1 infection and vaccination: pathways to preventing infection
inferred← citeshttps://doi.org/10.1016/j.molmed.2019.01.007openalex-snapshot
Broadly Neutralizing Antibodies against HIV: Back to Blood
inferred← citeshttps://doi.org/10.1016/j.nbt.2011.03.014openalex-snapshot
Single B cell antibody technologies
inferred← citeshttps://doi.org/10.1016/j.sbi.2016.07.012openalex-snapshot
Engineering antibody therapeutics
inferred← citeshttps://doi.org/10.1016/j.sbi.2025.103104openalex-snapshot
Review: Membrane protein nanodiscs for antibody discovery
inferred← citeshttps://doi.org/10.1016/j.smim.2021.101475openalex-snapshot
Broadly neutralizing antibodies for HIV-1 prevention and therapy
inferred← citeshttps://doi.org/10.1016/j.smim.2024.101864openalex-snapshot
Toolkit for mapping the clonal landscape of tumor-infiltrating B cells
inferred← citeshttps://doi.org/10.1016/j.tibs.2014.02.010openalex-snapshot
Thermodynamic stability contributes to immunoglobulin specificity
inferred← citeshttps://doi.org/10.1016/j.tim.2012.08.011openalex-snapshot
HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design
inferred← citeshttps://doi.org/10.1016/j.tim.2013.06.004openalex-snapshot
Catching HIV ‘in the act’ with 3D electron microscopy
inferred← citeshttps://doi.org/10.1016/j.tips.2009.09.005openalex-snapshot
Elucidating the elite: mechanisms of control in HIV-1 infection
inferred← citeshttps://doi.org/10.1016/j.tube.2016.08.001openalex-snapshot
Antibodies and tuberculosis
inferred← citeshttps://doi.org/10.1016/j.vaccine.2009.08.028openalex-snapshot
HIV inactivation by cross-linking of photo-labeled anti-retroviral compounds with HIV reverse transcriptase
inferred← citeshttps://doi.org/10.1016/j.vaccine.2010.02.002openalex-snapshot
Emerging studies of human HIV-specific antibody repertoires
inferred← citeshttps://doi.org/10.1016/j.vaccine.2010.02.006openalex-snapshot
Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.06.085openalex-snapshot
Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review
inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.01.026openalex-snapshot
Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.02.020openalex-snapshot
Profiling human antibody responses by integrated single-cell analysis
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.07.026openalex-snapshot
Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopes
showing the first 200 of 842 · page through all 842
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.